Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 62 | 2025 | 2257 | 9.220 |
Why?
|
Weight Loss | 47 | 2024 | 480 | 9.080 |
Why?
|
Exercise | 53 | 2025 | 787 | 8.170 |
Why?
|
Bone Density | 47 | 2025 | 318 | 7.450 |
Why?
|
Caloric Restriction | 32 | 2023 | 83 | 7.210 |
Why?
|
Life Style | 18 | 2025 | 406 | 4.710 |
Why?
|
Frail Elderly | 19 | 2022 | 68 | 4.570 |
Why?
|
Sarcopenia | 13 | 2025 | 40 | 4.330 |
Why?
|
Exercise Therapy | 17 | 2025 | 134 | 4.020 |
Why?
|
Hypogonadism | 15 | 2025 | 284 | 3.790 |
Why?
|
Testosterone | 17 | 2025 | 535 | 3.760 |
Why?
|
Diet, Reducing | 14 | 2022 | 89 | 3.750 |
Why?
|
Aging | 25 | 2025 | 1166 | 3.280 |
Why?
|
Body Composition | 34 | 2024 | 521 | 3.210 |
Why?
|
Resistance Training | 7 | 2022 | 31 | 2.950 |
Why?
|
Muscle, Skeletal | 17 | 2025 | 944 | 2.710 |
Why?
|
Hormone Replacement Therapy | 11 | 2025 | 196 | 2.550 |
Why?
|
Aged | 100 | 2025 | 19526 | 2.500 |
Why?
|
Diabetes Mellitus, Type 2 | 15 | 2024 | 1260 | 1.930 |
Why?
|
Overweight | 7 | 2019 | 362 | 1.850 |
Why?
|
Oxygen Consumption | 17 | 2021 | 304 | 1.630 |
Why?
|
Bone and Bones | 9 | 2022 | 265 | 1.570 |
Why?
|
Dehydroepiandrosterone | 8 | 2018 | 18 | 1.540 |
Why?
|
Bone Remodeling | 10 | 2021 | 55 | 1.530 |
Why?
|
Osteoporosis | 9 | 2021 | 116 | 1.530 |
Why?
|
Body Mass Index | 27 | 2023 | 1555 | 1.490 |
Why?
|
Incretins | 3 | 2024 | 24 | 1.330 |
Why?
|
Muscle Strength | 8 | 2020 | 73 | 1.320 |
Why?
|
Intra-Abdominal Fat | 4 | 2022 | 51 | 1.320 |
Why?
|
Insulin | 12 | 2017 | 1200 | 1.320 |
Why?
|
Muscle Proteins | 6 | 2019 | 417 | 1.300 |
Why?
|
Insulin Resistance | 10 | 2025 | 637 | 1.270 |
Why?
|
Humans | 153 | 2025 | 124122 | 1.210 |
Why?
|
Cognition | 6 | 2022 | 707 | 1.200 |
Why?
|
Quality of Life | 13 | 2025 | 1899 | 1.200 |
Why?
|
Male | 114 | 2025 | 60978 | 1.180 |
Why?
|
Fractures, Bone | 4 | 2023 | 186 | 1.130 |
Why?
|
Diet | 13 | 2021 | 1133 | 0.990 |
Why?
|
Hip | 5 | 2012 | 15 | 0.990 |
Why?
|
Frailty | 3 | 2022 | 83 | 0.980 |
Why?
|
Combined Modality Therapy | 10 | 2025 | 1223 | 0.980 |
Why?
|
C-Reactive Protein | 9 | 2023 | 427 | 0.960 |
Why?
|
Physical Fitness | 5 | 2012 | 87 | 0.950 |
Why?
|
Body Weight | 15 | 2017 | 996 | 0.950 |
Why?
|
Aged, 80 and over | 25 | 2025 | 6465 | 0.940 |
Why?
|
Energy Intake | 14 | 2023 | 493 | 0.920 |
Why?
|
Female | 99 | 2025 | 66250 | 0.850 |
Why?
|
Blood Glucose | 16 | 2015 | 1135 | 0.840 |
Why?
|
Healthy Aging | 2 | 2025 | 7 | 0.830 |
Why?
|
Metabolic Syndrome | 5 | 2021 | 338 | 0.820 |
Why?
|
Osteocalcin | 6 | 2022 | 42 | 0.790 |
Why?
|
Physical Endurance | 7 | 2017 | 43 | 0.760 |
Why?
|
Cellular Senescence | 1 | 2023 | 162 | 0.750 |
Why?
|
Adiponectin | 4 | 2016 | 113 | 0.740 |
Why?
|
Estradiol | 6 | 2022 | 534 | 0.710 |
Why?
|
Adiposity | 6 | 2022 | 190 | 0.710 |
Why?
|
Leptin | 5 | 2022 | 216 | 0.710 |
Why?
|
Double-Blind Method | 9 | 2025 | 1629 | 0.690 |
Why?
|
Absorptiometry, Photon | 13 | 2022 | 177 | 0.680 |
Why?
|
Glucose Tolerance Test | 12 | 2019 | 208 | 0.680 |
Why?
|
Middle Aged | 60 | 2025 | 26583 | 0.680 |
Why?
|
Transcriptome | 2 | 2025 | 946 | 0.680 |
Why?
|
Behavior Therapy | 2 | 2021 | 254 | 0.670 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2017 | 40 | 0.630 |
Why?
|
Adipose Tissue | 8 | 2020 | 460 | 0.620 |
Why?
|
Healthy Lifestyle | 1 | 2019 | 31 | 0.620 |
Why?
|
Osteoporosis, Postmenopausal | 5 | 2007 | 24 | 0.610 |
Why?
|
Activities of Daily Living | 5 | 2014 | 381 | 0.590 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 1941 | 0.580 |
Why?
|
Lumbar Vertebrae | 4 | 2018 | 113 | 0.580 |
Why?
|
Adjuvants, Immunologic | 3 | 2006 | 381 | 0.540 |
Why?
|
Serum Amyloid P-Component | 1 | 2016 | 14 | 0.540 |
Why?
|
Estrogen Replacement Therapy | 4 | 2003 | 44 | 0.530 |
Why?
|
Fasting | 2 | 2023 | 299 | 0.530 |
Why?
|
Insulin-Like Growth Factor I | 8 | 2015 | 340 | 0.510 |
Why?
|
Vitamin D | 5 | 2022 | 160 | 0.500 |
Why?
|
Biomarkers | 13 | 2024 | 3046 | 0.490 |
Why?
|
Energy Metabolism | 8 | 2020 | 774 | 0.450 |
Why?
|
Vitamin K Deficiency | 1 | 2014 | 3 | 0.450 |
Why?
|
Vitamin K | 1 | 2014 | 37 | 0.440 |
Why?
|
Inflammation | 5 | 2023 | 1421 | 0.430 |
Why?
|
Motor Activity | 2 | 2015 | 510 | 0.420 |
Why?
|
Hormones | 2 | 2011 | 186 | 0.410 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2003 | 14 | 0.400 |
Why?
|
Precision Medicine | 1 | 2015 | 315 | 0.400 |
Why?
|
Adult | 36 | 2025 | 29322 | 0.400 |
Why?
|
Glucose Intolerance | 2 | 2012 | 78 | 0.390 |
Why?
|
Coronary Disease | 4 | 2020 | 672 | 0.390 |
Why?
|
Phentermine | 1 | 2011 | 7 | 0.370 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 126 | 0.370 |
Why?
|
Cross-Sectional Studies | 11 | 2023 | 3414 | 0.370 |
Why?
|
Mobility Limitation | 2 | 2025 | 22 | 0.370 |
Why?
|
Anti-Obesity Agents | 1 | 2011 | 41 | 0.360 |
Why?
|
Protein Biosynthesis | 2 | 2011 | 664 | 0.360 |
Why?
|
Longevity | 3 | 2025 | 137 | 0.350 |
Why?
|
Gastric Inhibitory Polypeptide | 3 | 2016 | 19 | 0.350 |
Why?
|
Collagen Type I | 7 | 2022 | 112 | 0.350 |
Why?
|
Fructose | 1 | 2011 | 62 | 0.350 |
Why?
|
Feeding Behavior | 2 | 2014 | 711 | 0.350 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 17 | 0.330 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 632 | 0.330 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2024 | 70 | 0.330 |
Why?
|
Gait | 4 | 2017 | 83 | 0.330 |
Why?
|
Blood Pressure | 12 | 2019 | 1350 | 0.330 |
Why?
|
KATP Channels | 1 | 2009 | 6 | 0.330 |
Why?
|
Health Promotion | 3 | 2021 | 388 | 0.320 |
Why?
|
Postmenopause | 3 | 2020 | 126 | 0.320 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2009 | 34 | 0.320 |
Why?
|
Glucose | 5 | 2022 | 879 | 0.300 |
Why?
|
Treatment Outcome | 11 | 2025 | 12275 | 0.290 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 2517 | 0.290 |
Why?
|
Risk Factors | 15 | 2021 | 10241 | 0.290 |
Why?
|
C-Peptide | 4 | 2015 | 113 | 0.290 |
Why?
|
Aromatase | 2 | 2019 | 22 | 0.290 |
Why?
|
Fatty Liver | 1 | 2009 | 184 | 0.280 |
Why?
|
Soybean Proteins | 1 | 2007 | 17 | 0.280 |
Why?
|
Islets of Langerhans | 1 | 2008 | 174 | 0.280 |
Why?
|
Isoflavones | 1 | 2007 | 45 | 0.270 |
Why?
|
Missouri | 2 | 2016 | 36 | 0.270 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2015 | 31 | 0.260 |
Why?
|
Abdominal Fat | 3 | 2015 | 19 | 0.260 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2003 | 16 | 0.260 |
Why?
|
Alkaline Phosphatase | 4 | 2010 | 97 | 0.260 |
Why?
|
Dietary Proteins | 4 | 2019 | 250 | 0.260 |
Why?
|
DNA-Binding Proteins | 2 | 2025 | 2049 | 0.260 |
Why?
|
Genetic Variation | 2 | 2009 | 1493 | 0.260 |
Why?
|
Triglycerides | 3 | 2022 | 573 | 0.260 |
Why?
|
Follow-Up Studies | 5 | 2021 | 5132 | 0.250 |
Why?
|
Transcription Factors | 3 | 2025 | 2586 | 0.250 |
Why?
|
Adaptation, Physiological | 6 | 2015 | 271 | 0.240 |
Why?
|
Diet, Vegetarian | 1 | 2005 | 5 | 0.240 |
Why?
|
Peptides | 6 | 2017 | 792 | 0.240 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2025 | 9 | 0.240 |
Why?
|
Interleukin-6 | 4 | 2014 | 419 | 0.240 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2024 | 21 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 1102 | 0.230 |
Why?
|
Estrogens | 6 | 2004 | 514 | 0.230 |
Why?
|
Sex Factors | 5 | 2023 | 1276 | 0.230 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2020 | 19 | 0.220 |
Why?
|
Risk | 2 | 2016 | 754 | 0.220 |
Why?
|
Finite Element Analysis | 1 | 2023 | 27 | 0.220 |
Why?
|
Wnt Proteins | 1 | 2025 | 193 | 0.220 |
Why?
|
Hand Strength | 1 | 2023 | 39 | 0.220 |
Why?
|
Progesterone Congeners | 1 | 2003 | 6 | 0.220 |
Why?
|
Weight Reduction Programs | 2 | 2021 | 55 | 0.220 |
Why?
|
Vascular Stiffness | 2 | 2016 | 73 | 0.220 |
Why?
|
Muscle Weakness | 1 | 2004 | 83 | 0.220 |
Why?
|
beta Catenin | 1 | 2025 | 204 | 0.210 |
Why?
|
Biology | 1 | 2023 | 29 | 0.210 |
Why?
|
Time Factors | 11 | 2019 | 6279 | 0.200 |
Why?
|
Health Status | 3 | 2017 | 371 | 0.200 |
Why?
|
Weight Gain | 2 | 2024 | 404 | 0.200 |
Why?
|
Independent Living | 1 | 2022 | 61 | 0.190 |
Why?
|
Nutritional Requirements | 2 | 2014 | 181 | 0.190 |
Why?
|
Proteins | 2 | 2023 | 1035 | 0.190 |
Why?
|
Adipocytes | 2 | 2020 | 137 | 0.190 |
Why?
|
Bronchitis, Chronic | 1 | 2021 | 18 | 0.180 |
Why?
|
Patient Compliance | 4 | 2016 | 469 | 0.180 |
Why?
|
Hyperglycemia | 1 | 2022 | 222 | 0.170 |
Why?
|
STAT1 Transcription Factor | 1 | 2020 | 72 | 0.170 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 441 | 0.170 |
Why?
|
Femur Neck | 1 | 2019 | 9 | 0.170 |
Why?
|
Thigh | 2 | 2013 | 51 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2023 | 798 | 0.170 |
Why?
|
Pulmonary Emphysema | 1 | 2021 | 94 | 0.170 |
Why?
|
Hydrocortisone | 3 | 2016 | 217 | 0.160 |
Why?
|
Pilot Projects | 3 | 2020 | 1369 | 0.160 |
Why?
|
Prospective Studies | 8 | 2022 | 6117 | 0.160 |
Why?
|
Elder Nutritional Physiological Phenomena | 1 | 2019 | 2 | 0.160 |
Why?
|
Risk Assessment | 4 | 2018 | 3427 | 0.160 |
Why?
|
Calcium, Dietary | 1 | 2019 | 37 | 0.160 |
Why?
|
Spine | 2 | 2006 | 143 | 0.150 |
Why?
|
Exercise Test | 4 | 2017 | 251 | 0.150 |
Why?
|
Osteoblasts | 2 | 2025 | 148 | 0.150 |
Why?
|
Cytokines | 2 | 2016 | 1285 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 6 | 2016 | 3548 | 0.150 |
Why?
|
United States | 6 | 2021 | 10856 | 0.150 |
Why?
|
Reference Values | 2 | 2009 | 711 | 0.150 |
Why?
|
Metabolic Diseases | 1 | 2019 | 129 | 0.140 |
Why?
|
Comorbidity | 2 | 2018 | 1530 | 0.140 |
Why?
|
Femur | 3 | 2018 | 67 | 0.140 |
Why?
|
Insulin-Secreting Cells | 2 | 2009 | 149 | 0.140 |
Why?
|
Body Fluid Compartments | 1 | 2017 | 19 | 0.140 |
Why?
|
Physical Conditioning, Human | 1 | 2017 | 4 | 0.140 |
Why?
|
Postprandial Period | 2 | 2015 | 77 | 0.140 |
Why?
|
Illinois | 1 | 2016 | 13 | 0.130 |
Why?
|
Single-Blind Method | 1 | 2017 | 231 | 0.130 |
Why?
|
Genotype | 4 | 2009 | 2557 | 0.130 |
Why?
|
Alzheimer Disease | 1 | 2003 | 795 | 0.130 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 1085 | 0.130 |
Why?
|
Menopause | 3 | 2004 | 75 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 676 | 0.130 |
Why?
|
Signal Transduction | 4 | 2025 | 4498 | 0.130 |
Why?
|
Antibodies, Blocking | 1 | 2016 | 61 | 0.120 |
Why?
|
Diet Therapy | 1 | 2016 | 41 | 0.120 |
Why?
|
Feasibility Studies | 3 | 2015 | 746 | 0.120 |
Why?
|
Ventricular Function, Left | 4 | 2007 | 506 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2008 | 1008 | 0.120 |
Why?
|
Calcitonin | 2 | 1992 | 31 | 0.120 |
Why?
|
Time | 2 | 2017 | 93 | 0.120 |
Why?
|
Walking | 1 | 2017 | 159 | 0.120 |
Why?
|
Depression | 1 | 2023 | 1212 | 0.120 |
Why?
|
Muscular Atrophy | 1 | 2016 | 75 | 0.120 |
Why?
|
Exercise Tolerance | 1 | 2015 | 83 | 0.120 |
Why?
|
RNA | 2 | 2008 | 566 | 0.120 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 468 | 0.120 |
Why?
|
Troponin T | 1 | 2016 | 282 | 0.120 |
Why?
|
Risk Reduction Behavior | 2 | 2013 | 141 | 0.120 |
Why?
|
Endocrine Glands | 1 | 1994 | 10 | 0.120 |
Why?
|
Animals | 9 | 2023 | 34002 | 0.120 |
Why?
|
Nitric Oxide Synthase | 1 | 1995 | 186 | 0.110 |
Why?
|
Bone Resorption | 3 | 2008 | 41 | 0.110 |
Why?
|
Calcium | 4 | 2009 | 1099 | 0.110 |
Why?
|
Collagen | 3 | 2005 | 316 | 0.110 |
Why?
|
Research Design | 1 | 2018 | 687 | 0.110 |
Why?
|
Myostatin | 1 | 2013 | 19 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2017 | 1317 | 0.110 |
Why?
|
Asthma | 1 | 2021 | 743 | 0.110 |
Why?
|
Cognitive Dysfunction | 1 | 2017 | 227 | 0.110 |
Why?
|
Hip Joint | 1 | 2013 | 34 | 0.110 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 28 | 0.110 |
Why?
|
Triiodothyronine | 2 | 2015 | 62 | 0.110 |
Why?
|
Age Factors | 5 | 2020 | 2806 | 0.110 |
Why?
|
Leucine | 2 | 2011 | 311 | 0.100 |
Why?
|
Nutrition Policy | 1 | 2014 | 100 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2016 | 2816 | 0.100 |
Why?
|
Calcitriol | 1 | 1993 | 81 | 0.100 |
Why?
|
Osteosclerosis | 1 | 1992 | 12 | 0.100 |
Why?
|
Up-Regulation | 2 | 2012 | 857 | 0.100 |
Why?
|
Interleukin-1 | 1 | 1993 | 142 | 0.100 |
Why?
|
Substance Abuse, Intravenous | 1 | 1992 | 39 | 0.100 |
Why?
|
Peptide Fragments | 1 | 2016 | 777 | 0.100 |
Why?
|
Neurotensin | 1 | 2012 | 4 | 0.100 |
Why?
|
Acids | 1 | 2012 | 29 | 0.100 |
Why?
|
Linear Models | 1 | 2014 | 668 | 0.100 |
Why?
|
Placebos | 2 | 2011 | 240 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2009 | 54 | 0.100 |
Why?
|
Knee Joint | 1 | 2013 | 158 | 0.100 |
Why?
|
Area Under Curve | 3 | 2008 | 319 | 0.100 |
Why?
|
Organ Size | 3 | 2012 | 426 | 0.100 |
Why?
|
Glucagon | 2 | 2012 | 185 | 0.100 |
Why?
|
Mass Screening | 1 | 2018 | 781 | 0.100 |
Why?
|
Prevalence | 1 | 2018 | 2444 | 0.100 |
Why?
|
Surveys and Questionnaires | 3 | 2013 | 3682 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2014 | 276 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2014 | 2862 | 0.090 |
Why?
|
Tibia | 2 | 2022 | 69 | 0.090 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 567 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2015 | 20 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 328 | 0.090 |
Why?
|
Intention to Treat Analysis | 1 | 2011 | 64 | 0.090 |
Why?
|
Blood Chemical Analysis | 2 | 2011 | 80 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2011 | 111 | 0.090 |
Why?
|
Genetic Markers | 1 | 2012 | 604 | 0.090 |
Why?
|
Drug Combinations | 1 | 2011 | 265 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 822 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2014 | 476 | 0.080 |
Why?
|
Regression Analysis | 1 | 2011 | 777 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 1991 | 72 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 1018 | 0.080 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2009 | 24 | 0.080 |
Why?
|
Heart Failure | 3 | 2020 | 2287 | 0.080 |
Why?
|
Sulfonylurea Receptors | 1 | 2009 | 13 | 0.080 |
Why?
|
Receptors, Drug | 1 | 2009 | 38 | 0.080 |
Why?
|
Glucose Clamp Technique | 1 | 2009 | 76 | 0.080 |
Why?
|
Models, Biological | 2 | 2011 | 1453 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 2019 | 810 | 0.080 |
Why?
|
Osteitis | 1 | 2008 | 1 | 0.080 |
Why?
|
Arthropathy, Neurogenic | 1 | 2008 | 2 | 0.080 |
Why?
|
Osteolysis | 1 | 2008 | 9 | 0.080 |
Why?
|
Protein Deficiency | 1 | 2008 | 20 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 542 | 0.080 |
Why?
|
Glucocorticoids | 1 | 1991 | 380 | 0.080 |
Why?
|
Anaerobic Threshold | 1 | 2008 | 11 | 0.080 |
Why?
|
Diabetic Neuropathies | 1 | 2008 | 41 | 0.080 |
Why?
|
Intestinal Absorption | 2 | 2008 | 190 | 0.080 |
Why?
|
Amino Acids | 2 | 2009 | 663 | 0.070 |
Why?
|
Dietary Sucrose | 1 | 2008 | 41 | 0.070 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 189 | 0.070 |
Why?
|
Sex Characteristics | 4 | 2015 | 314 | 0.070 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 393 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2013 | 1696 | 0.070 |
Why?
|
Parathyroid Hormone | 2 | 2022 | 73 | 0.070 |
Why?
|
Muscular Diseases | 1 | 2008 | 103 | 0.070 |
Why?
|
Radioisotopes | 1 | 2007 | 38 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2007 | 78 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 143 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 1683 | 0.070 |
Why?
|
Leukocytes | 1 | 2008 | 204 | 0.070 |
Why?
|
Biopsy | 2 | 2009 | 1238 | 0.070 |
Why?
|
Prognosis | 3 | 2020 | 4608 | 0.070 |
Why?
|
Heart Rate | 5 | 2012 | 583 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2008 | 241 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 279 | 0.070 |
Why?
|
Diabetic Foot | 1 | 2008 | 121 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2009 | 344 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 2629 | 0.070 |
Why?
|
Weight-Bearing | 2 | 2021 | 35 | 0.070 |
Why?
|
Arteries | 2 | 2004 | 220 | 0.060 |
Why?
|
Advisory Committees | 2 | 2018 | 153 | 0.060 |
Why?
|
Women's Health | 1 | 2007 | 133 | 0.060 |
Why?
|
New Mexico | 2 | 2017 | 6 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2006 | 188 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 1282 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 276 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 520 | 0.060 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
Patient Selection | 1 | 2009 | 689 | 0.060 |
Why?
|
Lipids | 2 | 2015 | 512 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 579 | 0.060 |
Why?
|
Waist Circumference | 2 | 2017 | 90 | 0.060 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2004 | 82 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 427 | 0.060 |
Why?
|
Abdomen | 1 | 2004 | 127 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2006 | 355 | 0.050 |
Why?
|
Basal Metabolism | 2 | 2015 | 95 | 0.050 |
Why?
|
Osteogenesis | 1 | 2025 | 154 | 0.050 |
Why?
|
Postural Balance | 1 | 2004 | 79 | 0.050 |
Why?
|
Stroke Volume | 2 | 2003 | 484 | 0.050 |
Why?
|
Smoking | 1 | 2009 | 1043 | 0.050 |
Why?
|
Rome | 1 | 2023 | 7 | 0.050 |
Why?
|
Young Adult | 4 | 2019 | 8983 | 0.050 |
Why?
|
Italy | 1 | 2023 | 97 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2025 | 2087 | 0.050 |
Why?
|
DNA | 1 | 2008 | 1596 | 0.050 |
Why?
|
Demography | 1 | 2003 | 239 | 0.050 |
Why?
|
Osteoclasts | 1 | 2022 | 55 | 0.050 |
Why?
|
Follicle Stimulating Hormone | 1 | 2022 | 186 | 0.050 |
Why?
|
Radiography | 3 | 1992 | 824 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2025 | 544 | 0.050 |
Why?
|
Consensus | 1 | 2025 | 636 | 0.050 |
Why?
|
Lung Diseases | 1 | 2025 | 384 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2020 | 25 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2021 | 99 | 0.040 |
Why?
|
Dietary Carbohydrates | 2 | 2014 | 119 | 0.040 |
Why?
|
Network Meta-Analysis | 1 | 2020 | 27 | 0.040 |
Why?
|
Leadership | 1 | 2023 | 227 | 0.040 |
Why?
|
Calorimetry, Indirect | 2 | 2012 | 56 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 198 | 0.040 |
Why?
|
Aromatase Inhibitors | 1 | 2020 | 76 | 0.040 |
Why?
|
Survival Analysis | 1 | 2003 | 1491 | 0.040 |
Why?
|
Psychometrics | 1 | 2003 | 666 | 0.040 |
Why?
|
Lipoproteins | 1 | 2000 | 179 | 0.040 |
Why?
|
Musculoskeletal System | 1 | 2019 | 18 | 0.040 |
Why?
|
Base Sequence | 2 | 1995 | 3089 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2021 | 293 | 0.040 |
Why?
|
Blood Flow Velocity | 2 | 2012 | 434 | 0.040 |
Why?
|
Pelvic Bones | 1 | 2018 | 26 | 0.040 |
Why?
|
RNA Interference | 1 | 2020 | 494 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 3872 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2020 | 500 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 4389 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2019 | 257 | 0.040 |
Why?
|
Androgens | 1 | 2020 | 274 | 0.040 |
Why?
|
Heart | 1 | 2002 | 708 | 0.040 |
Why?
|
Metabolome | 1 | 2020 | 293 | 0.040 |
Why?
|
Disease Progression | 1 | 2003 | 2047 | 0.030 |
Why?
|
Torso | 1 | 2017 | 11 | 0.030 |
Why?
|
Bone Diseases, Metabolic | 1 | 2017 | 54 | 0.030 |
Why?
|
Lung | 1 | 2025 | 1476 | 0.030 |
Why?
|
Apolipoprotein E4 | 1 | 2017 | 44 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 174 | 0.030 |
Why?
|
Prostate | 1 | 2019 | 435 | 0.030 |
Why?
|
Homeostasis | 1 | 2020 | 685 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 116 | 0.030 |
Why?
|
Beclin-1 | 1 | 2016 | 26 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2016 | 135 | 0.030 |
Why?
|
Walk Test | 1 | 2016 | 23 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2016 | 68 | 0.030 |
Why?
|
Educational Status | 1 | 2017 | 273 | 0.030 |
Why?
|
Mice | 3 | 2020 | 17582 | 0.030 |
Why?
|
Diet, Sodium-Restricted | 1 | 1995 | 15 | 0.030 |
Why?
|
Diastole | 2 | 2007 | 170 | 0.030 |
Why?
|
Body Temperature | 1 | 2015 | 111 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 152 | 0.030 |
Why?
|
Sodium, Dietary | 1 | 1995 | 35 | 0.030 |
Why?
|
Hip Fractures | 1 | 2016 | 61 | 0.030 |
Why?
|
Physical Education and Training | 2 | 2005 | 20 | 0.030 |
Why?
|
Mice, Obese | 1 | 1995 | 73 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 195 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2016 | 398 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 1995 | 78 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 288 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2016 | 244 | 0.030 |
Why?
|
Mastication | 1 | 2014 | 6 | 0.030 |
Why?
|
Snacks | 1 | 2014 | 19 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2015 | 619 | 0.030 |
Why?
|
Edible Grain | 1 | 2014 | 45 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 1994 | 67 | 0.030 |
Why?
|
Growth Substances | 1 | 1994 | 113 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 355 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2014 | 74 | 0.030 |
Why?
|
Premenopause | 1 | 1993 | 31 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 2014 | 78 | 0.030 |
Why?
|
DNA Primers | 1 | 1995 | 656 | 0.030 |
Why?
|
Mitochondrial Turnover | 1 | 2013 | 3 | 0.030 |
Why?
|
Quadriceps Muscle | 1 | 2013 | 12 | 0.030 |
Why?
|
Forkhead Box Protein O3 | 1 | 2013 | 23 | 0.030 |
Why?
|
3T3 Cells | 1 | 1993 | 121 | 0.030 |
Why?
|
Cardiac Output | 2 | 2004 | 169 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1993 | 185 | 0.030 |
Why?
|
Hypothalamus | 1 | 1995 | 221 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1993 | 259 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2013 | 142 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2020 | 3718 | 0.030 |
Why?
|
Dietary Fats | 1 | 2014 | 295 | 0.020 |
Why?
|
Osteitis Deformans | 1 | 1992 | 7 | 0.020 |
Why?
|
Anemia | 1 | 2016 | 340 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1994 | 317 | 0.020 |
Why?
|
Lysine | 1 | 1992 | 194 | 0.020 |
Why?
|
Nutritional Status | 1 | 2014 | 313 | 0.020 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2016 | 504 | 0.020 |
Why?
|
Antibodies | 1 | 1993 | 372 | 0.020 |
Why?
|
Hydroxycholecalciferols | 1 | 1991 | 6 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 4254 | 0.020 |
Why?
|
Echocardiography | 2 | 2007 | 1048 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 357 | 0.020 |
Why?
|
Hepacivirus | 1 | 1992 | 241 | 0.020 |
Why?
|
Odds Ratio | 1 | 2014 | 1252 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 1031 | 0.020 |
Why?
|
Rats | 2 | 2013 | 3677 | 0.020 |
Why?
|
Keto Acids | 1 | 2009 | 56 | 0.020 |
Why?
|
Veterans | 1 | 2021 | 1749 | 0.020 |
Why?
|
Pain | 1 | 1992 | 447 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 1992 | 775 | 0.020 |
Why?
|
Phenylalanine | 1 | 2009 | 125 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1993 | 1389 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 1992 | 676 | 0.020 |
Why?
|
Blood Proteins | 1 | 2009 | 122 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2009 | 59 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 595 | 0.020 |
Why?
|
Skin Temperature | 1 | 2008 | 19 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 10 | 0.020 |
Why?
|
Thyroglobulin | 1 | 2008 | 7 | 0.020 |
Why?
|
Memory | 1 | 2012 | 362 | 0.020 |
Why?
|
Urine | 1 | 2008 | 90 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 547 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2008 | 51 | 0.020 |
Why?
|
Diet Records | 1 | 2008 | 74 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2008 | 52 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2016 | 1526 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2012 | 918 | 0.020 |
Why?
|
Hypertension | 1 | 2017 | 1316 | 0.020 |
Why?
|
Kinetics | 1 | 2009 | 1321 | 0.020 |
Why?
|
Computers | 1 | 2007 | 68 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 438 | 0.020 |
Why?
|
Vasodilation | 1 | 2008 | 190 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2008 | 310 | 0.020 |
Why?
|
Anthropometry | 1 | 2007 | 197 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2007 | 104 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2007 | 171 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2006 | 136 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1992 | 1151 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 481 | 0.020 |
Why?
|
Aerobiosis | 1 | 2005 | 14 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2004 | 107 | 0.010 |
Why?
|
Lower Extremity | 1 | 2006 | 180 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 471 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2004 | 143 | 0.010 |
Why?
|
Elasticity | 1 | 2004 | 90 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2004 | 258 | 0.010 |
Why?
|
Phosphorylation | 1 | 2008 | 1613 | 0.010 |
Why?
|
Rest | 1 | 2003 | 57 | 0.010 |
Why?
|
Systole | 1 | 2003 | 198 | 0.010 |
Why?
|
Software | 1 | 2007 | 677 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 2037 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 3265 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2002 | 265 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 2882 | 0.010 |
Why?
|
Alleles | 1 | 2004 | 1620 | 0.010 |
Why?
|
Dihydropyridines | 1 | 1995 | 8 | 0.010 |
Why?
|
Nitrobenzenes | 1 | 1995 | 19 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 1995 | 65 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1992 | 16264 | 0.010 |
Why?
|
Angiotensin II | 1 | 1995 | 163 | 0.010 |
Why?
|
Nephrectomy | 1 | 1995 | 177 | 0.010 |
Why?
|
Piperazines | 1 | 1995 | 237 | 0.010 |
Why?
|
Biological Availability | 1 | 1992 | 135 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1992 | 149 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 1995 | 412 | 0.010 |
Why?
|